Primary GlaucomaNCT06071494
The Effect Of Tropical Fruits In Patients With Primary Glaucoma
A study testing Tropical fruits in people with Primary Glaucoma, run by Universiti Sains Malaysia at 1 site in Malaysia.
Trial summary
To evaluate the effect of regular tropical fruits intake in primary glaucoma patients. Methodology : Research Design Randomized controlled trial Study Duration February 2024-June 2025 Study Location 1. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Primary Glaucoma
- What is being tested?
- Tropical fruits
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 104 participants
- Where
- 1 siteMalaysia
- Study dates
- 1 Feb 2024to 1 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patient with confirmed diagnosis of POAG and PACG
- Patient on medical treatment and achieved target IOP in last 6 months
- Good compliance with pressure lowering agents
Who cannot join
- Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
- Active smoker
- Mentally challenge based on diagnosis
- History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
- Poor signal strength OCT RNFL
- Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
- Other optic neuropathy apart from glaucoma
- History of taking antioxidant supplement 3 months prior to recruitment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized Controlled Trial Of The Effect Of Tropical Fruits On Intraocular Pressure And Retinal Nerve Fibre Layer Thickness In Patients With Primary Glaucoma
To evaluate the effect of regular tropical fruits intake in primary glaucoma patients.
Methodology :
Research Design Randomized controlled trial
Study Duration February 2024-June 2025
Study Location
- Ophthalmology Clinic, Hospital Universiti Sains Malaysia, Kelantan
Source Reference Population Adults with primary glaucoma in Peninsular Malaysia
Study Source Population Adults with primary glaucoma attending Ophthalmology clinic, Hospital Universiti Sains Malaysia during study duration.
Read the detailed description
General objective To evaluate the effect of regular tropical fruits intake on intra-ocular pressure (IOP) and retinal nerve fibre layer thickness (RNFL) in primary glaucoma patients.
Research hypothesis
- There is a significant different in the IOP measurement between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
- There is a significant different in RNFL thickness between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
Inclusion Criteria
- Patient with confirmed diagnosis of POAG and PACG
- Patient on medical treatment and achieved target IOP in last 6 months
- Good compliance with pressure lowering agents
Exclusion Criteria
- Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
- Active smoker
- Mentally challenge based on diagnosis
- History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
- Poor signal strength OCT RNFL
- Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
- Other optic neuropathy apart from glaucoma
- History of taking antioxidant supplement 3 months prior to recruitment.
Methods of Data Collection
This study will be conducted after obtaining ethical approval from the Universiti Sains Malaysia Ethical Committee (JPeM) and will be conducted in accordance to World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects.
Recruitment of Subject
Patient diagnosed with POAG and PACG attending Ophthalmology clinic, Hospital USM during study duration and fulfilled study inclusion and exclusion criteria. An informed and written consent will be taken and information form given to patients. The selected patients will be randomized into 2 groups (A and B) using sequentially numbered, opaque sealed envelopes (SNOSE). Group A patient will be consuming the chosen fruits and group B patient will not consume them.
Interventional Protocol
Patients in Group A will have to consume 2 types of fresh fruits per week as 2 servings once per day, daily for a 6-month duration. The chosen fruits are papaya, banana, mango and orange, and 2 types of fruits per week will be determined by the primary investigator. Size of the servings is according to the Malaysian Dietary Guideline 2020. They must eat them raw, and not to process or cook them in any other way. The fruits will be distributed by research assistant weekly throughout the study period. Patient will be reminded weekly using text messages or phone call by a research assistant for the fruit's consumption. Patients in group A and group B will be given a dietary diary throughout the study period, where the patient will mark the intake of fruits listed. The purpose of the diary is also to monitor patient intake of the fruits and daily diet as well.
IOP measurement
IOP measurement will be done using Goldmann Applanation Tonometer (GAT) in sitting position by the primary investigator (Nurul Munirah) who will be blinded. GAT will be calibrated daily before use to measure the IOP. Measurement of IOP will be done only at 8am - 10am (to prevent diurnal variation). Before IOP measurement, subjects are advised to avoid drinking coffee or any caffeinated drink 24 hours before and only to take light meal 2 hours before (to reduce the effect of hyperglycaemia and hydration on IOP). Only one eye will be measured, if both eyes are eligible, only right eye will be selected regardless of severity of glaucoma. Three readings of IOP will be measured and the mean reading will be taken as result. IOP measurement will be taken at baseline, first, third and sixth month post recruitment for group A and B.
OCT evaluation on RNFL thickness
Spectral domain Cirrus HD-OCT will be used to measure RNFL thickness and ONH parameters by a trained personnel who is blinded. Patient's eye will be dilated and patient will sit and rest his/her head on a support to keep it motionless in front of the OCT machine. The OCT will then scan patient's eye without touching it. Scans with signal strength less than 6, eye movement or blinking artifacts within the 1.73-mm radius around the ONH, or with segmentation errors will be repeated. If there is unsatisfactory measurement after 3 attempts, the patient will be excluded from the study. OCT will be conducted at baseline, first, third and sixth month post recruitment for group A and B.
Data Entry and Statistical Analysis
The data entry and analysis will be performed by using Statistical Package for the Social Sciences (SPSS) version 29 licensed to USM.
- Paired T-test
- Chi-square test
- A one-way repeated measures analysis of variance (RM ANOVA)
Plans for minimizing study errors
These steps will be taken to minimize the errors while conducting the study:
- The same instruments and equipment will be used for repeated measurement in this study.
- The measurement of IOP will be done at the same time (8am-10am) in a day for all patients (to prevent diurnal variation).
- OCT measurements will be performed by qualified and trained personnel only.
- Conditions
- Primary Glaucoma
- Being tested
- Tropical fruits
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Tropical fruitsOther
papaya, mango, banana, orange
| Study group | Role | What they receive |
|---|---|---|
| Tropical Fruits | Experimental | patient will be consuming the chosen fruits, according to the size of the serving following Malaysian Dietary Guideline 2020 Receives: Other: Tropical fruits |
| Normal diet | No intervention | patient will consume normal diet as usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
intraocular pressure
tonometer
Measured: baseline, at 1 month , at 3 months and 6 months
retinal nerve fibre layer
Spectral domain Cirrus HD-OCT
Measured: baseline, at 1 month , at 3 months and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Oct 2023
- Study start1 Feb 2024
- Primary completion1 Jan 2025
- Study completion1 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Primary GlaucomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 104 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universiti Sains Malaysia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, NURUL MUNIRAH BINTI MOHAMAD, Universiti Sains Malaysia
- Investigators
- Nurul Munirah Mohamad, Dr, Principal investigator, Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.Liza Sharmini Ahmad Tajudin, Prof. Dr., Study chair, Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.Rohana Abd Jalil, Ass. Prof., Study director, Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.Fatimah Suhaila Sukaimy, Dr, Study director, Department of Ophthalmology Hospital Tengku Ampuan Afzan, Ministry of Health, Malaysia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06071494
- Sponsor's protocol ID
- RSCH ID-23-03744-7U6
- Status last verified
- Jul 2025
- First submitted
- 1 Oct 2023
- Last updated
- 17 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004 May 22;363(9422):1711-20. doi: 10.1016/S0140-6736(04)16257-0.
PubMed 15158634Braakhuis A, Raman R, Vaghefi E. The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases. 2017 Jan 30;5(1):3. doi: 10.3390/diseases5010003.
PubMed 28933356Kang JH, Willett WC, Rosner BA, Buys E, Wiggs JL, Pasquale LR. Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study. JAMA Ophthalmol. 2016 Mar;134(3):294-303. doi: 10.1001/jamaophthalmol.2015.5601.
PubMed 26767881Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9944-8. doi: 10.1073/pnas.96.17.9944.
PubMed 10449799
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial Of The Effect Of Tropical Fruits On Intraocular Pressure And Retinal Nerve Fibre Layer Thickness In Patients With Primary Glaucoma
- ClinicalTrials.gov ID
- NCT06071494
- Acronym / sponsor ID
- RSCH ID-23-03744-7U6
- Conditions
- Primary Glaucoma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 104 participants (actual)
- Lead sponsor
- Universiti Sains MalaysiaUniversity, hospital or other
- Study start
- 1 Feb 2024 (actual)
- Primary completion
- 1 Jan 2025 (actual)
- Study completion
- 1 May 2025 (actual)
- First posted
- 6 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the effect of regular tropical fruits intake in primary glaucoma patients.
Methodology :
Research Design Randomized controlled trial
Study Duration February 2024-June 2025
Study Location
- Ophthalmology Clinic, Hospital Universiti Sains Malaysia, Kelantan
Source Reference Population Adults with primary glaucoma in Peninsular Malaysia
Study Source Population Adults with primary glaucoma attending Ophthalmology clinic, Hospital Universiti Sains Malaysia during study duration.
Detailed description
General objective To evaluate the effect of regular tropical fruits intake on intra-ocular pressure (IOP) and retinal nerve fibre layer thickness (RNFL) in primary glaucoma patients.
Research hypothesis
- There is a significant different in the IOP measurement between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
- There is a significant different in RNFL thickness between those whose taking regular tropical fruits and not taking them at baseline, 1 month, 3 month and 6 month among patients with primary glaucoma.
Inclusion Criteria
- Patient with confirmed diagnosis of POAG and PACG
- Patient on medical treatment and achieved target IOP in last 6 months
- Good compliance with pressure lowering agents
Exclusion Criteria
- Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
- Active smoker
- Mentally challenge based on diagnosis
- History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
- Poor signal strength OCT RNFL
- Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
- Other optic neuropathy apart from glaucoma
- History of taking antioxidant supplement 3 months prior to recruitment.
Methods of Data Collection
This study will be conducted after obtaining ethical approval from the Universiti Sains Malaysia Ethical Committee (JPeM) and will be conducted in accordance to World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects.
Recruitment of Subject
Patient diagnosed with POAG and PACG attending Ophthalmology clinic, Hospital USM during study duration and fulfilled study inclusion and exclusion criteria. An informed and written consent will be taken and information form given to patients. The selected patients will be randomized into 2 groups (A and B) using sequentially numbered, opaque sealed envelopes (SNOSE). Group A patient will be consuming the chosen fruits and group B patient will not consume them.
Interventional Protocol
Patients in Group A will have to consume 2 types of fresh fruits per week as 2 servings once per day, daily for a 6-month duration. The chosen fruits are papaya, banana, mango and orange, and 2 types of fruits per week will be determined by the primary investigator. Size of the servings is according to the Malaysian Dietary Guideline 2020. They must eat them raw, and not to process or cook them in any other way. The fruits will be distributed by research assistant weekly throughout the study period. Patient will be reminded weekly using text messages or phone call by a research assistant for the fruit's consumption. Patients in group A and group B will be given a dietary diary throughout the study period, where the patient will mark the intake of fruits listed. The purpose of the diary is also to monitor patient intake of the fruits and daily diet as well.
IOP measurement
IOP measurement will be done using Goldmann Applanation Tonometer (GAT) in sitting position by the primary investigator (Nurul Munirah) who will be blinded. GAT will be calibrated daily before use to measure the IOP. Measurement of IOP will be done only at 8am - 10am (to prevent diurnal variation). Before IOP measurement, subjects are advised to avoid drinking coffee or any caffeinated drink 24 hours before and only to take light meal 2 hours before (to reduce the effect of hyperglycaemia and hydration on IOP). Only one eye will be measured, if both eyes are eligible, only right eye will be selected regardless of severity of glaucoma. Three readings of IOP will be measured and the mean reading will be taken as result. IOP measurement will be taken at baseline, first, third and sixth month post recruitment for group A and B.
OCT evaluation on RNFL thickness
Spectral domain Cirrus HD-OCT will be used to measure RNFL thickness and ONH parameters by a trained personnel who is blinded. Patient's eye will be dilated and patient will sit and rest his/her head on a support to keep it motionless in front of the OCT machine. The OCT will then scan patient's eye without touching it. Scans with signal strength less than 6, eye movement or blinking artifacts within the 1.73-mm radius around the ONH, or with segmentation errors will be repeated. If there is unsatisfactory measurement after 3 attempts, the patient will be excluded from the study. OCT will be conducted at baseline, first, third and sixth month post recruitment for group A and B.
Data Entry and Statistical Analysis
The data entry and analysis will be performed by using Statistical Package for the Social Sciences (SPSS) version 29 licensed to USM.
- Paired T-test
- Chi-square test
- A one-way repeated measures analysis of variance (RM ANOVA)
Plans for minimizing study errors
These steps will be taken to minimize the errors while conducting the study:
- The same instruments and equipment will be used for repeated measurement in this study.
- The measurement of IOP will be done at the same time (8am-10am) in a day for all patients (to prevent diurnal variation).
- OCT measurements will be performed by qualified and trained personnel only.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Tropical Fruits | Experimental | Other: Tropical fruitspatient will be consuming the chosen fruits, according to the size of the serving following Malaysian Dietary Guideline 2020 |
| Normal diet | No intervention | –patient will consume normal diet as usual |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patient with confirmed diagnosis of POAG and PACG
- Patient on medical treatment and achieved target IOP in last 6 months
- Good compliance with pressure lowering agents
Key exclusion criteria (8 listed)
- Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
- Active smoker
- Mentally challenge based on diagnosis
- History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
- Poor signal strength OCT RNFL
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Tropical fruitspapaya, mango, banana, orange | Other | Tropical Fruits |
Primary outcome
intraocular pressure
Time frame: baseline, at 1 month , at 3 months and 6 months
tonometer
retinal nerve fibre layer
Time frame: baseline, at 1 month , at 3 months and 6 months
Spectral domain Cirrus HD-OCT
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2025.
- Background: PubMed 15158634Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004 May 22;363(9422):1711-20. doi: 10.1016/S0140-6736(04)16257-0.
- Background: PubMed 28933356Braakhuis A, Raman R, Vaghefi E. The Association between Dietary Intake of Antioxidants and Ocular Disease. Diseases. 2017 Jan 30;5(1):3. doi: 10.3390/diseases5010003.
- Background: PubMed 26767881Kang JH, Willett WC, Rosner BA, Buys E, Wiggs JL, Pasquale LR. Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up Study. JAMA Ophthalmol. 2016 Mar;134(3):294-303. doi: 10.1001/jamaophthalmol.2015.5601.
- Background: PubMed 10449799Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9944-8. doi: 10.1073/pnas.96.17.9944.
- Primary open-angle glaucomaLink provided by the sponsor.
- The Association between Dietary Intake of Antioxidants and Ocular Disease. DiseasesLink provided by the sponsor.
- Association of Dietary Nitrate Intake With Primary Open-Angle Glaucoma: A Prospective Analysis From the Nurses' Health Study and Health Professionals Follow-up StudyLink provided by the sponsor.
- Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucomaLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Primary Glaucoma
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Retinitis Pigmentosa (RP), Rod Cone Dystrophy
RecruitingPhase 2
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Recruiting
The Acute Effect of Exercise Type And Timing on Ambulatory Blood Pressure and Intra-Ocular Pressure in Individuals With Glaucoma (The ACHIEVE-project).
Glaucoma Open-Angle Primary, Hypertension
RecruitingObservational study
Anterior Segment Anatomy Assessed by Swept-Source OCT in Ocular Surgery Patients
Cataract, Primary Angle-Closure Glaucoma
RecruitingObservational study
PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group
Primary Open Angle Glaucoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nurul Munirah Mohamad, Dr principal investigator
Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.
Liza Sharmini Ahmad Tajudin, Prof. Dr. study chair
Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.
Rohana Abd Jalil, Ass. Prof. study director
Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Tropical fruits in people with Primary Glaucoma, run by Universiti Sains Malaysia at 1 site in Malaysia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
intraocular pressure (time frame: baseline, at 1 month , at 3 months and 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06071494, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2025.